How to achieve greater comparability-suggested ways to improve the determination of treatment gap and treatment lag. Issue 1 (16th October 2020)

• Record Type: Journal Article
• Authors: Schaub, Michael Patrick
• Is Part Of: Drugs and alcohol today. Volume 21:Issue 1(2021)
• Page Start: 45
• Page End: 53
• Publication Date: 2020-10-16
• Subjects: Alcohol use disorder -- Prevalence -- Treatment gap -- Treatment lag -- Recommendations; Drug abuse -- Periodicals; Alcoholism -- Periodicals; 362.2905
• DOI: 10.1108/DAT-07-2020-0049
• Languages: English
• ISSNs: 1745-9265

Abstract

Abstract : Purpose: The aim of this paper is to reveal these problems and to derive recommendations for improvement. In the field of alcohol use disorders (AUDs), two common complaints are the large treatment gap that exists because only a small percentage of people with an AUD are in treatment; and the prolonged lag that typically exists between the emergence of problematic symptoms and actual on set of treatment. However, there also are no clear definitions for these terms – "treatment gap" and "treatment lag" – and, therefore, no consensus regarding how to quantify them. For this reason, it is difficult to compare the results of studies assessing either of these measures. Design/methodology/approach: A non-systematic literature search and logical-analytical investigation was performed of immanent problems related to definitions and measurements aiming to enhance understanding in this area and derive suggestions for improvement. Findings: The following four fundamental questions were identified: How does one operationalise the need to change substance use behaviours? Which interventions can justifiably be called treatment? Is treatment always necessary? and How regularly do patients need to be in contact with a treatment system to be considered "in treatment"? Potential approaches to answering these questions are discussed and recommendations made for future studies to determine how the treatment gap and treatment lag should be derived. Originality/value: The derived recommendations should make the calculation of treatment gap and treatment lag more transparent and comparable between studies. They also may serve as checklists for future studies on the treatment gap and lag in the AUD field.